BrYet US

Manufacturing · Texas, United States · 1-10 Employees

View Company Info for Free

Overview

Headquarters

2450 Holcombe Blvd Ste 1520, Houston, Te...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About BrYet US

BrYet is a privately-owned biotech company dedicated to discovering and developing first-in-class therapies for primary and metastatic cancers, particularly those affecting the lungs and liver. The company aims to create fully curative approaches to metastatic cancer through innovative multi-component therapeutics targeting transport phenotypes. Their research has shown unprecedented efficacy in preclinical trials and is supported by a robust patent portfolio. BrYet's intended clients include patients suffering from otherwise incurable cancers, as well as the broader medical community seeking advanced treatment options.Explore more
BrYet US's Social MediaPopular SearchesBrYet US IncBrYetSIC Code 28,283NAICS Code 32,325Show more

BrYet US Org Chart

Mauro Ferrari, President, Chief Executive Officer & Chairman & Founder, Scientific at BrYet US
United States flag for contact location.

President, Chief Executive Officer & Chairman...

PhoneEmail
GB
United States flag for contact location.

Chief Financial Officer

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is BrYet US your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to BrYet US

Compare insights from companies similar to BrYet US, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

BrYet US

<$5M
1-10
Private
-
-
Mauro Ferrari, President, Chief Executive Officer & Chairman & Founder, Scientific at BrYet US
Mauro FerrariPresident, CEO & Chairman & Founder, Scientific
<$5M
1-10
Private
-
2018
<$5M
11-50
Private
-
2020
PO
Phil OakleyVice President, Public Sector Drug Discovery & Development
<$5M
11-50
Private
-
-
N/A
<$5M
1-10
Private
-
2017
Julie Saiki, Co-founder & Chief Operating Officer at Azora Therapeutics
Julie SaikiCo-founder & Chief Operating Officer
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

BrYet US is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

BrYet US is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about BrYet US.

BrYet US Tech Stack

A closer look at the technologies used by BrYet US

Top Manufacturing Companies

Frequently Asked Questions Regarding BrYet US

What is BrYet US's official website?
BrYet US's official website is www.bryetpharma.com
What is BrYet US's Revenue?
BrYet US's revenue is <$5 Million
What is BrYet US's SIC code?
BrYet US's SIC: 28,283
What is BrYet US's NAICS code?
BrYet US's NAICS: 32,325
How many employees does BrYet US have?
BrYet US has 1-10 employees
What industry does BrYet US belong to?
BrYet US is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is BrYet US competition?
BrYet US top competitors include: Azora Therapeutics, Aplife Biotech, resistanceBio, Xeptiva Therapeutics
What technology does BrYet US use?
Some of the popular technologies that BrYet US uses are: WooCommerce, WordPress.org, PHP, Cloudflare Website Optimization
Who is the CFO of BrYet US?
BrYet US's CFO is Gary Brewster
What does BrYet US do?

BrYet is a privately-owned biotech company dedicated to discovering and developing first-in-class therapies for primary and metastatic cancers, particularly those affecting the lungs and liver. The company aims to create fully curative approaches to metastatic cancer through innovative multi-component therapeutics targeting transport phenotypes. Th... eir research has shown unprecedented efficacy in preclinical trials and is supported by a robust patent portfolio. BrYet's intended clients include patients suffering from otherwise incurable cancers, as well as the broader medical community seeking advanced treatment options.Read More

What are BrYet US social media links?
BrYet US Linkedin page
Is BrYet US a public company?
BrYet US is private company therefore does not currently have an official ticker symbol
See more information about BrYet US

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.